Upcoming Events
  1. TACT Board Teleconference (closed)

    August 28 - August 29
  2. ESMO 2017 Congress, Madrid Spain

    September 8 - September 12
  3. ***UPDATED*** 3rd ALTG Preceptorship in Lung Cancer, Melbourne VIC

    September 22 @ 12:00 pm - September 23 @ 5:00 pm UTC+10
  4. TACT General Assembly (closed), Yokohama Japan

    October 15
  5. 18th WCLC, Yokohama Japan

    October 15 - October 18

ALTG 06/003 NITRO

A phase III, multi-centre randomised trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer.

The trial opened in May 2009 with recruitment closing in April 2014, with 372 patients randomised from 29 active sites. Follow-up has been completed and all sites are to be closed by December. The study results were presented at ESMO 2014 and ALLC 2014 and the final results have been submitted for publication.

Contacts

Study Chair: Andrew Davidson

Email: andrew.davidson@health.wa.gov.au

CTC Trial Coordinator: Nick Muljadi

Email: nitro@ctc.usyd.edu.au